Andrew Mandlsohn
Senior Associate, Toronto
Barrister and Solicitor


Phone: 416.593.5514
Fax: 416.591.1690
Download V-Card
Massachusetts Bar 2003
Ontario Bar 2006
  • Massachusetts College of Pharmacy B.Sc. (Pharmacy) 1998
  • Suffolk University Law School J.D. (concentration in health and biomedical law) 2003
  • Registered Pharmacist (Massachusetts Board of Registration in Pharmacy)
  • Registered Pharmacist - Part A (permitted to provide direct patient care) (Ontario College of Pharmacists)

Andrew’s practice focuses exclusively in the life sciences arena where he assists companies navigate and overcome complex legal and regulatory challenges. With a client-centric approach and a deep knowledge and understanding of the pharmaceutical industry, Andrew advises and advocates on behalf of innovative companies in litigation in the Ontario and Federal Courts, including under the Patented Medicines (Notice of Compliance) Regulations (patent validity, infringement and damages quantification). Andrew also provides strategic advice on issues impacting their businesses, including regulatory compliance (under the Food and Drugs Act and associated regulations), pricing and reimbursement (such as matters within the jurisdiction of the Patented Medicine Prices Review Board and under applicable provincial legislation) and requests for disclosure made under federal and provincial acts. Andrew takes great pride in building positive and effective relationships with his clients, which enables them to work together to find better solutions and allows him to contribute meaningfully to the success of their businesses. Andrew is also committed to lifelong learning, with some of his more recent pursuits being the completion of a series of professional development courses on drafting effective business documents and taking part in a dual certificate regulatory affairs program on medical devices and pharmaceuticals.

Prior to joining Smart & Biggar, Andrew worked at a U.S. State Department of Public Health (Division of Food and Drug), hospital, retail community and specialty pharmacies, a leading American biopharmaceutical company (Division of Regulatory Strategy and Intelligence), and a leading national law firm where he specialized in pharmaceutical litigation (patents and product liability). Through these experiences, and as a lawyer and pharmacist licenced to practice in both Canada and the U.S., Andrew has acquired significant knowledge of the laws governing the life science and healthcare industries, as well as expertise in pharmacy practice (including pharmacotherapy, drug interchangeability and reimbursement).

While pursuing his pharmacy degree at the Massachusetts College of Pharmacy, Andrew was elected to The Rho Chi Society (the academic honour society in pharmacy). Upon graduation he was recognized with an Award of Excellence for high academic achievement and outstanding communication skills. Andrew attended Suffolk University Law School where he attained the highest standing in his Health Law course and obtained a Concentration Certificate in Health and Biomedical Law.

In his spare time, Andrew enjoys bargain hunting, the thrill of online art auctions and rooting for Toronto sports teams.

Rankings and recognition

Recognized as an 'Rising Star' in Life Sciences since the inaugural edition in 2015 of LMG Expert Guides: Rising Stars

IP Management & Strategic Counselling
Life Sciences — Regulatory & Compliance
Life Sciences

Federal Court and Federal Court of Appeal

Apotex Inc v AstraZeneca Canada Inc2018 FC 181

AstraZeneca Canada Inc v Mylan Pharmaceuticals ULC2017 FC 142

Alcon Canada Inc v Apotex Inc2014 FC 791

AstraZeneca Canada Inc v Teva Canada Limited2013 FC 245

Apotex Inc v Sanofi-Aventis2012 FC 553

Sanofi-Aventis Canada Inc v Teva Canada Limited2012 FC 552

AstraZeneca Canada Inc. v. Mylan Pharmaceuticals ULC2011 FC 1023

Sanofi Aventis Canada Inc v Teva Canada Limited2010 FC 1210, aff’d 2011 FCA 149

Apotex Inc v Sanofi Aventis2010 FC 1209

Sanofi-Aventis Canada Inc. v. Apotex Inc.; Sanofi-Aventis Canada Inc. v. Novopharm Inc.2009 FC 676

Sanofi-Aventis Canada Inc v. Novopharm Limited2009 FC 1285

AstraZeneca Canada Inc v Apotex Inc2008 FC 1301

Abbott Laboratories v Canada (Health)2007 FC 753

Abbott Laboratories v Canada (Minister of Health)2006 FC 1558

Apotex Inc v. Abbott Laboratories2006 FCA 294

Ontario Superior Court

Apotex Inc v Eli Lilly and Company, 2015 ONSC 5396

Apotex Inc v Eli Lilly and Company, 2014 ONSC 3574

Apotex Inc v Schering Corporation, 2013 ONSC 1411

Domain Name Arbitration

Di-El Industrie-Electronic GmbH and TR Electronic v. E-Orderdesk, Case No. D2007-0961


  • Associate, Intellectual Property Institute of Canada
  • Member, The Advocates' Society
  • Member, Toronto Intellectual Property Group
  • Member, Canadian Association of Professionals in Regulatory Affairs
  • Member, Regulatory Affairs Professionals Society
  • Member, Ontario Bar Association; member of the Civil Litigation and Intellectual Property sections


web design toronto Rebel Trail